Silicon Valley Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Silicon Valley Capital Partners's AMGN Position: Q1 2026 in Review
Silicon Valley Capital Partners increased its Amgen (AMGN) stake by 0.62% in Q1 2026, buying an estimated $1.07K and bringing the position to 487 shares worth $171K. The position accounts for 0.02% of the portfolio, ranked #104.
Silicon Valley Capital Partners first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $177K in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Silicon Valley Capital Partners held 487 shares of Amgen worth $171K as of Q1 2026.
- Silicon Valley Capital Partners bought 3 Amgen shares in Q1 2026, an estimated $1.07K.
- Amgen made up 0.02% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #104 holding.
- Silicon Valley Capital Partners first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
- Silicon Valley Capital Partners's Amgen position peaked at $177K in Q3 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.